BackVeradermicsorporated Overview

Veradermicsorporated Receivables

Veradermicsorporated's receivables is $1.7M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.65M

Peer average

Loading

Veradermicsorporated Receivables History

Loading

Veradermicsorporated vs. peers: Receivables Comparison

Loading

Veradermicsorporated Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Veradermicsorporated (MANE) FAQ

As of the most recent data (March 2026), MANE shows a receivables of $1.7M. Scroll down for historical charts and peer comparison views.

Tracking MANE's receivables over time shows whether Veradermicsorporated is scaling, shrinking, or reshaping that part of the business. The current reading is $1.7M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Veradermicsorporated's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.7M) with ownership activity and broader fundamentals.

Veradermicsorporated's receivables is $1.7M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.